Drug and Medical Device Safety: Product Liability (Podcast 3 of 4)

The Global Pharmaceutical Center presents a series of four podcasts that delve deep into issues from Progressions 2007, The Ernst & Young Global Pharmaceutical Report. By registering for this series, you'll have access to each podcast as it is released.

Podcast 3 - Product Liability

When the quality of a pharmaceutical product is compromised, the financial risks that arise --through product liability litigation and product recalls-- range from mild to catastrophic. How are companies using risk management strategy to limit liability and exposure? What should pharma CEOs/CFOs be thinking about in order to mitigate the financial risks? Hear a discussion on the financial risks and other issues posed by product safety -- in particular, how executives across the enterprise should be addressing product liability and recalls.


Other Webcasts & Podcasts

The Obama administration and the new Congress:

Good medicine for the pharma, biotech, and medtech industries?

February 20, 2009

image

Released on:
Monday, October 01, 2007

(n/a
n/a your local time)

Duration: 22 minutes

Note: the webcast technology is not compatible with the browser you are using. Use Internet Explorer or Firefox.

Ernst & Young refers to one or more of the member firms of Ernst & Young Global Limited (EYG), a UK private company limited by guarantee. EYG is the principal governance entity of the global Ernst & Young organization and does not provide any services to clients. Services are provided by EYG member firms. Each of EYG and its member firms is a separate legal entity and has no liability for another such entity's acts or omissions. Certain content on this site may have been prepared by one or more EYG member firms.